BIOMONITOR IV and SmartECG Enable Workflow Optimization and Personalized Treatment Decisions1-7
BIOTRONIK announced the CE approval and first European implant of its latest insertable cardiac monitor (ICM). The BIOMONITOR IV features artificial intelligence (AI) for false positive reduction. It is the only ICM on the market with premature ventricular and atrial contraction (PVC and PAC) discrimination capabilities,1,2 as well as industry-leading signal quality and transmission success for highly reliable remote patient management.3